Klatskin tumor (Review of literature)
Abstract
The aim of review. Article reviews of cumulated literature data on the rare form of cholangiocarcinoma in bifurcation of hepatic ducts and named after Gerald Klatskin.
Key points. Obstructive jaundice at the absence of abdominal pain is leading clinical symptom of this disease. The histological pattern is represented by adenocarcinoma of acinar, tubular, trabecular, alveolar or papillary types. Bismuth-Corlette classification, that allows more precise differentiation of hepatic ducts lesion localization, is presented; diagnostic methods are discussed in details.
Conclusion. Difficulties of diagnosis and verification of Klatskin tumor determine a broad field for differential diagnostics. By virtue of low frequency disease represents a serious problem in assessment of cholestatic syndrome origin.
About the Authors
I. V. Mayev
State educational government-financed institution of higher professional education «Moscow State University of Medicine and Dentistry named after A.I. Evdokimov» Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
D. T. Dicheva
State educational government-financed institution of higher professional education «Moscow State University of Medicine and Dentistry named after A.I. Evdokimov» Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
D. N. Andreyev
State educational government-financed institution of higher professional education «Moscow State University of Medicine and Dentistry named after A.I. Evdokimov» Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
T. V. Penkina
Federal healthcare government agency «Main clinical hospital Ministry of Internal Affairs of the Russian Federation»
Russian Federation
Russian Federation
References
1. Вишневский В.А., Тарасюк Т.И. Диагностика и хирургическое лечение рака проксимальных отделов внепеченочных желчных протоков (опухоль Клатскина)// Практическая онкология. – 2004. – Т. 5, № 2. – С. 126–134.
2. Ультразвуковая диагностика в абдоминальной и сосудистой хирургии / Под. ред. Кунцевич Г.И. – Минск, 1999. – 252 с.
3. Федоров В.Д., Вишневский В.А., Кубышкин В.А. и др. Хирургическое лечение рака общего печеночного протока // Кремлевская мед. – 2000. – № 2. – С. 13–16.
4. Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma:
5. –2009. World J Gastroenterol. 2009; 15 (34):4240–62.
6. Bamrungphon W, Prempracha N, Bunchu N, et al. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma. Cancer Lett. 2007; 247:301–8.
7. Chen CY, Shiesh SC, Tsao HC, Lin XZ. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma – the influence of sampling time and hepatolithiasis. Hepatogastroenterology. 2002; 49:616–20.
8. Dawson JL, Heaton ND. Carcinoma of the biliary tree and gallbladder. Surgery Inter Edit. 2006; 17:84–8.
9. De Groen PC, Gores GJ, LaRusso NF, et al. Biliary tract cancers. NEJM. 1999; 341 (18):1368–78.
10. Hann LE, Getrajdman GI, Brown KT, et al. Hepatic lobar atrophy: association with ipsilateral portal vein obstruction. AJR Am J Roentgenol. 1996; 167:1017–21.
11. Hochwald SN, Burke EC, Jarnagin WR, et al. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg. 1999; 134:261–6.
12. Klatskin G. Adenocarcinoma of the hepatic ducts at its bifurcation within the porta hepatis. Am J Med, 1965; 38:241–56.
13. Kuang D, Wang G. Hilar cholangiocarcinoma: Pathology and tumor biology. Front Med China 2010; 4:371–7.
14. Lee HY, Kim SH, Lee JM, et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology. 2006; 239:113–21.
15. Mihalache F, Tantau M, Diaconu B, et al. M. Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period. J Gastrointestin Liver Dis 2010; 9:285–90.
16. NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. V 1.2011. 1. National Comprehensive Cancer Network.
17. Ortner MA. Photodynamic therapy in cholangiocarcinomas. Best Pract Res Clin Gastroenterol. 2004; 18:147–54.
18. Ouchi K, Matsuno S, Sato T. Long – term survival in carcinoma of biliary tract. Arch Surg. 2007; 124:248–52.
19. Patel T. Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol. 2006; 3:33–42.
20. Rang HP, Dale MM, Ritter JM, Flower RJ. Rang and Dale’s Pharmacology. Elsevier Churchill Livingstone. 2007. – 792 p.
21. Romagnuolo J, Bardou M, Rahme E, et al. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med. 2003; 139:547–57.
22. Slattery JM, Sahani DV. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist. 2006; 11:913–22.
23. Somer L, Andrejić B, Milošević P. Origin and pathological characteristics of Klatskin tumor: a case report and literature review. Pol J Pathol. 2012; 63 (1):65–70.
24. Su CH, Tsay SH, Wu CC, et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg. 1996; 223:384–94.
25. Thongprasert S. The role of chemotherapy in cholangiocarcinoma. Ann Oncol. 2005; 16 (suppl 2):93–6.
26. Todoroki T, Kawamoto T, Koike N, et al. Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg. 2000; 87:306–13.
27. Tsuzuki T, Ogata Y, Lida S, et al. Carcinoma of the bifurcation of the hepatic ductus. Arch. Surg. 1987; 205 (2):111–8.
Review
For citations:
Mayev I.V., Dicheva D.T., Andreyev D.N., Penkina T.V. Klatskin tumor (Review of literature). Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2013;23(3):33-38. (In Russ.)
Views:
82
Email this article 
